清肺止痉活血法治疗儿童支原体肺炎的临床效果观察

摘要

目的 探究清肺止痉活血法治疗儿童支原体肺炎的临床疗效.方法 我院收治的支原体肺炎患儿92例,随机均分为两组,对照组予以阿奇霉素治疗,观察组在此基础上予以清肺止痉活血法治疗,观察对比两组临床疗效及用药安全性.结果 观察组总有效率为93.5％,明显高于对照组的78.3％,差异有统计学意义(x2=4.39,P＜0.05);观察组退热时间[(3.1±1.2)d]、止咳时间[(4.1±1.4)d]、肺部啰音消失时间[(5.2±1.6)d]、住院时间[(7.4±1.5)d]均短于对照组[(5.6±1.5)d、(7.8±1.6)d、(7.9±1.3)d、(9.8±1.4)d],差异均有统计学意义(P＜0.05);两组用药期间未发生严重药物不良反应.结论 小儿支原体肺炎患儿予以清肺止痉活血法治疗的效果明显,安全可靠.%Objective To explore the clinical curative effect ofQingfei Huoxue antispasmodic prescription in the treatment of mycoplasma pneumonia in children.Methods 92 children with mycoplasma pneumonia in our hospital were randomly divided into two groups.Control group was given azithromycin treatment,and observation group was given Qingfei Huoxue antispasmodic prescription treatment on the basis.Observed and compared the clinical curative effect and drug safety of two groups.Results The total efficiency of observation group was 93.5％,significantly higher than 78.3％ of control group,with statistically significant difference (x 2=4.39,P＜0.05).The pyretolysis time,cough time,rales disappearing time,hospitalization time of observation group were significantly shorter than those of control group [(3.1±1.2)d vs.(5.6±1.5)d,(4.1±1.4)d vs.(7.8±1.6)d,(5.2±1.6)d vs.(7.9±1.3)d,(7.4±1.5)d vs.(9.8±1.4)d],with statistically significant differences (P＜0.05).There were no severe adverse reactions durig the treatment in two groups.Conclusion Qingfei Huoxue antispasmodic prescription has obvious effect in the treatment of mycoplasma pneumonia in children,safe and reliable.